MD

Mahaveer Dhariwal

Active Director Director DIN 11893880
DIN 11893880 First appointment Sep 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahaveer Dhariwal

Data last updated:

Mahaveer Dhariwal is a Director at Zota Health Care Limited (since 2026). The company operates in Pharma.

DIN 11893880
Primary Designation Director
Industry Pharma
First Appointment 03 Sep 2026
Oldest Company Age 26 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zota Health Care Limited L24231GJ2000PLC038352
Director03 Sep 20262000Active

Directorship timeline

Open interactive timeline →
Zota Health Care Limited
Premium access

Shareholding and investment profile for Mahaveer Dhariwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahaveer Dhariwal

Mahaveer Dhariwal currently holds 1 directorship: Zota Health Care Limited (Director, since 03 Sep 2026).

Mahaveer Dhariwal was first appointed on 03 Sep 2026 as Director at Zota Health Care Limited.

The current boards of Mahaveer Dhariwal's companies include Ashvin Bhagavanbhai Variya (Zota Health Care Limited), Bhumi Maulik Doshi (Zota Health Care Limited), Dhaval Chandubhai Patwa (Zota Health Care Limited), Dhiren Prafulbhai Shah (Zota Health Care Limited), Himanshu Muktilal Zota (Zota Health Care Limited), Jayshreeben Nileshkumar Mehta (Zota Health Care Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available